175 results
Page 3 of 9
8-K/A
EX-10.1
siynw
21 Nov 18
Departure of Directors or Certain Officers
4:10pm
425
EX-10.3
pgbjhv
21 Sep 18
Business combination disclosure
4:06pm
425
EX-10.1
86f5pga6lolky 28r
21 Sep 18
Business combination disclosure
4:06pm
425
EX-10.2
e04ksgft 2xa5j
21 Sep 18
Business combination disclosure
4:06pm
8-K
EX-10.3
cppp717ijfk
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.1
8k0fe hq5
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.2
psswpp
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.2
xw55wwrue0134puejtul
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
z093x
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
2i47xd9
18 Jul 18
Cancer Genetics Closes $2.625 million Convertible Note Financing
4:18pm
8-K
EX-10.1
hkssmxc 2iuifu9
5 Jul 18
Entry into a Material Definitive Agreement
4:59pm
8-K
EX-10.1
j5i9 b3wf1a43rkrg0
27 Jun 18
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
9d9zy3pzubaa2ktn3
27 Apr 18
Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
9:26am